We did a search of the DDL Blog for “continuing violation” and found only one other reference and that was simply to note that the court rejected the theory without explanation. So, it’s not the first time a plaintiff has tried to argue the continuing violation theory to avoid the statute of limitations in a
We believe in personal responsibility. That’s one reason why we’re even more offended about the Mirapex litigation than about most other pharma/medical device lawsuits. These plaintiffs try to blame a drug for their own atrocious conduct. Thus we’re pleased to note that in Scelta v. Boehringer Ingelheim Pharmaceuticals, Inc., slip op. (8th Cir. Dec.